الابحاث

South Egypt Cancer Institute

Assiut University

Department of Clinical Pathology
# Title Research Member Research Year
21 Clinical Outcome of Pediatric Acute Myeloid Leukemia Treated at South Egypt Cancer Institute, Assiut University, Egypt Dr. Iman Hassan Ahmed Hamada 2021
22 Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: a possible prognostic marker
 		Dr. Asmaa Mohamed Zahran Omar 2021
23 HLA-B* 15 predicts survival in Egyptian patients with COVID-19 Prof. Rania / Mohamed Mohamed / Bakri / El-Aton 2021
24 Risk of drug resistance and repeated infection with Klebsiella pneumoniae and Escherichia coli in intensive care unit cancer patients Dr. Iman Hassan Ahmed Hamada 2021
25 Higher CD19+ CD25+ Bregs are independently associated with better graft function in renal transplant recipients Prof. Douaa Mohamed Sayed Hussein 2021
26 Higher CD19+ CD25+ Bregs are independently associated with better graft function in renal transplant recipients Prof. Douaa Mohamed Sayed Hussein 2021
27 Higher CD19+ CD25+ Bregs are independently associated with better graft function in renal transplant recipients Dr. Iman Hassan Ahmed Hamada 2021
28 Higher CD19+ CD25+ Bregs are independently associated with better graft function in renal transplant recipients Eman Hosny Mohammed Ibrahim 2021
29 Interleukin-10: A Potential Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma Duaa Abdel-Samia Mohamed Ali 2021
30 Risk of drug resistance and repeated infection with Klebsiella pneumoniae and Escherichia coli in intensive care unit cancer patients Dr. Iman Hassan Ahmed Hamada 2021